Novo Nordisk A/S (NVO) - Risk-Adjusted Returns & Sharpe Ratio | pfolio
Novo Nordisk A/S (NVO): 1Y return -25.1%, Sharpe ratio -0.28, volatility 50.7%, max drawdown -49.2%. A Stock in the Equity asset class. Compare NVO with other assets and invest through your own broker with pfolio.
Novo Nordisk A/S (NVO) Overview
- Type: Stock
- Asset Class: Equity
- Region: Europe
- Country: DK (Developed)
- Currency: USD
NVO Performance
- MTD
- Return: 2.8%, Sharpe: 2.96, Volatility: 27.3%, Max Drawdown: -3.1%
- YTD
- Return: 0.4%, Sharpe: 0.27, Volatility: 50.1%, Max Drawdown: -43.7%
- 1Y
- Return: -25.1%, Sharpe: -0.28, Volatility: 50.7%, Max Drawdown: -49.2%
- 5Y
- Return: 26.6%, Sharpe: 0.31, Volatility: 37.8%, Max Drawdown: -74.7%
- 10Y
- Return: 124.3%, Sharpe: 0.41, Volatility: 32.0%, Max Drawdown: -74.7%
Frequently Asked Questions
- What is Novo Nordisk A/S (NVO)?
- Novo Nordisk A/S (NVO) is a Stock in the Equity asset class. pfolio shows its cumulative return, volatility, Sharpe ratio, and max drawdown across MTD, YTD, 1Y, 5Y, 10Y, 20Y, and all-time periods.
- How does NVO compare to other assets?
- You can compare NVO with any other asset using pfolio's comparison tool, which ranks assets side-by-side by risk-adjusted returns.
- Can I invest in NVO through pfolio?
- pfolio helps you build diversified portfolios that may include NVO. You invest through your own broker — pfolio provides the analytics.